Beneficial effects of intravenous iron therapy in a rat model of heart failure with preserved systemic iron status but depleted intracellular cardiac stores
Abstract Iron deficiency (ID) commonly occurs in chronic heart failure (HF) and is associated with poor prognosis. Neither its causes nor pathophysiological significance are clearly understood. We aimed to assess iron status and the effect of iron supplementation in the rat model of post-myocardial...
Main Authors: | Aleksandra Paterek, Marta Kępska, Barbara Sochanowicz, Ewelina Chajduk, Joanna Kołodziejczyk, Halina Polkowska-Motrenko, Marcin Kruszewski, Przemysław Leszek, Urszula Mackiewicz, Michał Mączewski |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2018-10-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-018-33277-2 |
Similar Items
-
Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
by: Jesse M. G. Hofman, et al.
Published: (2018-09-01) -
A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anemia during pregnancy in a tertiary care hospital
by: Sandip Kumar Ghosh, et al.
Published: (2024-04-01) -
Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients
by: Guy Rostoker, et al.
Published: (2022-07-01) -
Parenteral Iron Therapy for Pediatric Patients
by: Elpis Mantadakis, et al.
Published: (2024-01-01) -
A rare case of parental iron-induced persistent hypophosphatemia
by: Abigayle Sullivan, et al.
Published: (2020-03-01)